Elanco Animal Health Incorporated
ELAN
Rang in aandelen
#1817
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Aandeelprijs
$23.54
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$11.76B
Verandering (1 dag)
0.17%
Verandering (1 jaar)
9.90%
Land
US
Handel Elanco Animal Health Incorporated (ELAN)
Categorie
Healthcare
Operationele marge voor Elanco Animal Health Incorporated (ELAN)
Operationele marge op October 2026 TTM: 9.20%
Volgens de meest recente financiële rapporten en aandelenkoers van Elanco Animal Health Incorporated is de huidige operationele marge (TTM) 9.20%. Eind 2023 had het bedrijf een operationele marge van 7.38%.
Geschiedenis van de operationele marge van Elanco Animal Health Incorporated van 2015 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 9.20% | 62.83% |
| 2024 | 5.65% | -23.44% |
| 2023 | 7.38% | -15.27% |
| 2022 | 8.71% | 36.52% |
| 2021 | 6.38% | -371.49% |
| 2020 | -2.35% | -119.50% |
| 2019 | 12.05% | 17.79% |
| 2018 | 10.23% | 107.51% |
| 2017 | 4.93% | -49.28% |
| 2016 | 9.72% | 5,015.79% |
| 2015 | 0.19% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -97.51% |
IN
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.